Julia Beck
Overview
Explore the profile of Julia Beck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
1517
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Atila C, Beck J, Refardt J, Erlic Z, Drummond J, Sailer C, et al.
Eur J Endocrinol
. 2024 Mar;
190(5):354-362.
PMID: 38551325
Objective: Distinguishing arginine vasopressin deficiency (AVP-D; central diabetes insipidus) from primary polydipsia (PP), commonly referred to as psychogenic polydipsia, is challenging. Psychopathologic findings, commonly used for PP diagnosis in clinical...
12.
Beck J, Siebenhuner A, Wild D, Christ E, Refardt J
Endocr Relat Cancer
. 2023 Dec;
31(3).
PMID: 38117915
Sex differences affect the management of several diseases in both male and female patients. However, the influence of sex on neuroendocrine neoplasms (NENs) has been scarcely investigated. Thus, this study...
13.
Akifova A, Budde K, Choi M, Oellerich M, Beck J, Bornemann-Kolatzki K, et al.
Kidney Int Rep
. 2023 Oct;
8(10):2141-2145.
PMID: 37849995
No abstract available.
14.
Osmanodja B, Akifova A, Oellerich M, Beck J, Bornemann-Kolatzki K, Schutz E, et al.
J Clin Med
. 2023 Mar;
12(6).
PMID: 36983437
Donor-derived cell-free DNA (dd-cfDNA) is used as a biomarker for detection of antibody-mediated rejection (ABMR) and other forms of graft injury. Another potential indication is guidance of immunosuppressive therapy when...
15.
Muller F, Lim J, Bebber C, Seidel E, Tishina S, Dahlhaus A, et al.
Cell Death Differ
. 2022 Nov;
30(2):442-456.
PMID: 36443441
Oncogenic KRAS is the key driver oncogene for several of the most aggressive human cancers. One key feature of oncogenic KRAS expression is an early increase in cellular reactive oxygen...
16.
Oellerich M, Budde K, Osmanodja B, Bornemann-Kolatzki K, Beck J, Schutz E, et al.
Front Genet
. 2022 Nov;
13:1031894.
PMID: 36339004
There is a need to improve personalized immunosuppression in organ transplantation to reduce premature graft loss. Biomarkers are needed to better detect rejection, asymptomatic graft injury, and under-immunosuppression. Assessment of...
17.
Sender S, Sultan A, Palmer D, Koczan D, Sekora A, Beck J, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230614
Both bromodomain and extra-terminal domain (BET) proteins and spleen tyrosine kinase (SYK) represent promising targets in diffuse large B-cell (DLBCL) and Burkitt's lymphoma (BL). We evaluated the anti-lymphoma activity of...
18.
Granados-Soler J, Taher L, Beck J, Bornemann-Kolatzki K, Brenig B, Nerschbach V, et al.
Sci Rep
. 2022 Oct;
12(1):17025.
PMID: 36220861
The molecular heterogeneity of feline mammary carcinomas (FMCs) represents a prognostic and therapeutic challenge. RNA-Seq-based comparative transcriptomic profiling serves to identify recurrent and exclusive differentially expressed genes (DEGs) across sample...
19.
Oellerich M, Budde K, Osmanodja B, Bornemann-Kolatzki K, Beck J, Schutz E, et al.
Ther Drug Monit
. 2022 Sep;
45(1):20-25.
PMID: 36127770
Background: The long-term outcomes of solid organ transplantation remain suboptimal. Therefore, appropriate biomarkers are needed in addition to immunosuppressive drugs and other traditional approaches for graft monitoring to achieve personalized...
20.
Burkart V, Kowalski K, Aldag-Niebling D, Beck J, Frick D, Holler T, et al.
Front Cardiovasc Med
. 2022 Sep;
9:987889.
PMID: 36082122
Transcriptional bursting is a common expression mode for most genes where independent transcription of alleles leads to different ratios of allelic mRNA from cell to cell. Here we investigated burst-like...